{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T06:17:57Z","timestamp":1791353877019,"version":"4.3.1"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2014,9,5]],"date-time":"2014-09-05T00:00:00Z","timestamp":1409875200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1186\/1471-2334-14-486","type":"journal-article","created":{"date-parts":[[2014,9,5]],"date-time":"2014-09-05T17:01:18Z","timestamp":1409936478000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":68,"title":["Antimicrobial susceptibilities of Proteus mirabilis: a longitudinal nationwide study from the Taiwan surveillance of antimicrobial resistance (TSAR) program"],"prefix":"10.1186","volume":"14","author":[{"given":"Jann-Tay","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pei-Chen","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shan-Chwen","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yih-Ru","family":"Shiau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui-Ying","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jui-Fen","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I-Wen","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mei-Chen","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsai-Ling Yang","family":"Lauderdale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"TSAR Hospitals","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,9,5]]},"reference":[{"key":"3787_CR1","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/S0966-842X(00)88945-3","volume":"3","author":"HL Mobley","year":"1995","unstructured":"Mobley HL, Belas R: Swarming and pathogenicity of Proteus mirabilis in the urinary tract. Trends Microbiol. 1995, 3: 280-284. 10.1016\/S0966-842X(00)88945-3.","journal-title":"Trends Microbiol"},{"key":"3787_CR2","first-page":"65","volume":"61","author":"A Rozalski","year":"1997","unstructured":"Rozalski A, Sidorczyk Z, Kotelko K: Potential virulence factors of Proteus bacilli. Microbiol Mol Biol Rev. 1997, 61: 65-89.","journal-title":"Microbiol Mol Biol Rev"},{"key":"3787_CR3","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1093\/infdis\/146.6.719","volume":"146","author":"JW Warren","year":"1982","unstructured":"Warren JW, Tenney JH, Hoopes JM, Muncie HL, Anthony WC: A prospective microbiologic study of bacteriuria in patients with chronic indwelling urethral catheters. J Infect Dis. 1982, 146: 719-723. 10.1093\/infdis\/146.6.719.","journal-title":"J Infect Dis"},{"key":"3787_CR4","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1016\/0895-4356(89)90096-6","volume":"42","author":"CM Kunin","year":"1989","unstructured":"Kunin CM: Blockage of urinary catheters: role of microorganisms and constituents of the urine on formation of encrustations. J Clin Epidemiol. 1989, 42: 835-842. 10.1016\/0895-4356(89)90096-6.","journal-title":"J Clin Epidemiol"},{"key":"3787_CR5","doi-asserted-by":"publisher","first-page":"1930","DOI":"10.1128\/AAC.44.7.1930-1935.2000","volume":"44","author":"C Chanal","year":"2000","unstructured":"Chanal C, Bonnet R, De Champs C, Sirot D, Labia R, Sirot J: Prevalence of \u03b2-lactamases among 1,072 clinical strains of Proteus mirabilis: a 2-year survey in a French hospital. Antimicrob Agents Chemother. 2000, 44: 1930-1935. 10.1128\/AAC.44.7.1930-1935.2000.","journal-title":"Antimicrob Agents Chemother"},{"key":"3787_CR6","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1128\/AAC.01009-09","volume":"54","author":"K Bush","year":"2010","unstructured":"Bush K, Jacoby GA: Updated functional classification of \u03b2-lactamases. Antimicrob Agents Chemother. 2010, 54: 969-976. 10.1128\/AAC.01009-09.","journal-title":"Antimicrob Agents Chemother"},{"key":"3787_CR7","doi-asserted-by":"publisher","first-page":"2735","DOI":"10.1128\/AAC.01736-10","volume":"55","author":"MM D\u2019Andrea","year":"2011","unstructured":"D\u2019Andrea MM, Literacka E, Zioga A, Giani T, Baraniak A, Fiett J, Sadowy E, Tassios PT, Rossolini GM, Gniadkowski M, Miriagou V: Evolution and spread of a multidrug-resistant Proteus mirabilis clone with chromosomal AmpC-type cephalosporinases in Europe. Antimicrob Agents Chemother. 2011, 55: 2735-2742. 10.1128\/AAC.01736-10.","journal-title":"Antimicrob Agents Chemother"},{"key":"3787_CR8","doi-asserted-by":"publisher","first-page":"1727","DOI":"10.1099\/jmm.0.049726-0","volume":"61","author":"R Nakano","year":"2012","unstructured":"Nakano R, Nakano A, Abe M, Inoue M, Okamoto R: Regional outbreak of CTX-M-2 \u03b2-lactamase-producing Proteus mirabilis in Japan. J Med Microbiol. 2012, 61: 1727-1735. 10.1099\/jmm.0.049726-0.","journal-title":"J Med Microbiol"},{"key":"3787_CR9","doi-asserted-by":"publisher","first-page":"2598","DOI":"10.1128\/AAC.49.7.2598-2605.2005","volume":"49","author":"A Endimiani","year":"2005","unstructured":"Endimiani A, Luzzaro F, Brigante G, Perilli M, Lombardi G, Amicosante G, Rossolini GM, Toniolo A: Proteus mirabilis bloodstream infections: risk factors and treatment outcome related to the expression of extended-spectrum \u03b2-lactamases. Antimicrob Agents Chemother. 2005, 49: 2598-2605. 10.1128\/AAC.49.7.2598-2605.2005.","journal-title":"Antimicrob Agents Chemother"},{"key":"3787_CR10","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1016\/j.mib.2010.09.006","volume":"13","author":"K Bush","year":"2010","unstructured":"Bush K: Alarming \u03b2-lactamase-mediated resistance in multidrug-resistant Enterobacteriaceae. Curr Opin Microbiol. 2010, 13: 558-564. 10.1016\/j.mib.2010.09.006.","journal-title":"Curr Opin Microbiol"},{"key":"3787_CR11","doi-asserted-by":"publisher","first-page":"1791","DOI":"10.3201\/eid1710.110655","volume":"17","author":"P Nordmann","year":"2011","unstructured":"Nordmann P, Naas T, Poirel L: Global spread of carbapenemase-producing Enterobacteriaceae. Emerg Infect Dis. 2011, 17: 1791-1798. 10.3201\/eid1710.110655.","journal-title":"Emerg Infect Dis"},{"key":"3787_CR12","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1017\/S0950268813000988","volume":"142","author":"CS Horner","year":"2014","unstructured":"Horner CS, Abberley N, Denton M, Wilcox MH: Surveillance of antibiotic susceptibility of Enterobacteriaceae isolated from urine samples collected from community patients in a large metropolitan area, 2010\u20132012. Epidemiol Infect. 2014, 142: 399-403. 10.1017\/S0950268813000988.","journal-title":"Epidemiol Infect"},{"key":"3787_CR13","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1007\/s10096-012-1737-0","volume":"32","author":"E Miro","year":"2013","unstructured":"Miro E, Aguero J, Larrosa MN, Fernandez A, Conejo MC, Bou G, Gonzalez-Lopez JJ, Lara N, Martinez-Martinez L, Oliver A, Aracil B, Oteo J, Pascual A, Rodriguez-Bano J, Zamorano L, Navarro F: Prevalence and molecular epidemiology of acquired AmpC \u03b2-lactamases and carbapenemases in Enterobacteriaceae isolates from 35 hospitals in Spain. Eur J Clin Microbiol Infect Dis. 2013, 32: 253-259. 10.1007\/s10096-012-1737-0.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"3787_CR14","doi-asserted-by":"publisher","first-page":"2981","DOI":"10.1128\/AAC.00971-12","volume":"57","author":"WH Sheng","year":"2013","unstructured":"Sheng WH, Badal RE, Hsueh PR: Distribution of extended-spectrum \u03b2-lactamases, AmpC \u03b2-lactamases, and carbapenemases among Enterobacteriaceae isolates causing intra-abdominal infections in the Asia-Pacific region: results of the Study for Monitoring Antimicrobial Resistance Trends (SMART). Antimicrob Agents Chemother. 2013, 57: 2981-2988. 10.1128\/AAC.00971-12.","journal-title":"Antimicrob Agents Chemother"},{"key":"3787_CR15","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1016\/j.clinthera.2013.03.022","volume":"35","author":"SK Bouchillon","year":"2013","unstructured":"Bouchillon SK, Badal RE, Hoban DJ, Hawser SP: Antimicrobial susceptibility of inpatient urinary tract isolates of gram-negative bacilli in the United States: results from the Study for Monitoring Antimicrobial Resistance Trends (SMART) program: 2009\u20132011. Clin Ther. 2013, 35: 872-877. 10.1016\/j.clinthera.2013.03.022.","journal-title":"Clin Ther"},{"key":"3787_CR16","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.jinf.2013.09.001","volume":"68","author":"SP Hawser","year":"2014","unstructured":"Hawser SP, Badal RE, Bouchillon SK, Hoban DJ, Hackel MA, Biedenbach DJ, Goff DA: Susceptibility of gram-negative aerobic bacilli from intra-abdominal pathogens to antimicrobial agents collected in the United States during 2011. J Infect. 2014, 68: 71-76. 10.1016\/j.jinf.2013.09.001.","journal-title":"J Infect"},{"key":"3787_CR17","doi-asserted-by":"publisher","first-page":"5600","DOI":"10.1128\/AAC.01485-13","volume":"57","author":"JA Karlowsky","year":"2013","unstructured":"Karlowsky JA, Adam HJ, Baxter MR, Lagace-Wiens PR, Walkty AJ, Hoban DJ, Zhanel GG: In vitro activity of ceftaroline-avibactam against gram-negative and gram-positive pathogens isolated from patients in Canadian hospitals from 2010 to 2012: results from the CANWARD surveillance study. Antimicrob Agents Chemother. 2013, 57: 5600-5611. 10.1128\/AAC.01485-13.","journal-title":"Antimicrob Agents Chemother"},{"key":"3787_CR18","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1016\/j.diagmicrobio.2013.11.025","volume":"78","author":"HS Sader","year":"2014","unstructured":"Sader HS, Farrell DJ, Flamm RK, Jones RN: Antimicrobial susceptibility of gram-negative organisms isolated from patients hospitalized in intensive care units in United States and European hospitals (2009\u20132011). Diagn Microbiol Infect Dis. 2014, 78: 443-448. 10.1016\/j.diagmicrobio.2013.11.025.","journal-title":"Diagn Microbiol Infect Dis"},{"key":"3787_CR19","volume-title":"Performance Standards for Antimicrobial Susceptibility Testing. Twenty-Fourth Informational Supplement. M100-S24. Clinical and Laboratory Standards Institute","author":"Clinical and Laboratory Standards Institute","year":"2014","unstructured":"Clinical and Laboratory Standards Institute: Performance Standards for Antimicrobial Susceptibility Testing. Twenty-Fourth Informational Supplement. M100-S24. Clinical and Laboratory Standards Institute. 2014, Wayne, PA: CLSI, Document M100-S24"},{"key":"3787_CR20","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1093\/jac\/40.3.365","volume":"40","author":"HE Villar","year":"1997","unstructured":"Villar HE, Danel F, Livermore DM: Permeability to carbapenems of Proteus mirabilis mutants selected for resistance to imipenem or other \u03b2-lactams. J Antimicrob Chemother. 1997, 40: 365-370. 10.1093\/jac\/40.3.365.","journal-title":"J Antimicrob Chemother"},{"key":"3787_CR21","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/j.ijantimicag.2013.02.001","volume":"41","author":"SS Jean","year":"2013","unstructured":"Jean SS, Hsueh PR, Lee WS, Yu KW, Liao CH, Chang FY, Ko WC, Wu JJ, Chen YH, Chen YS, Liu JW, Lu MC, Liu CY, Lam C, Chen RJ: Carbapenem susceptibilities and non-susceptibility concordance to different carbapenems amongst clinically important gram-negative bacteria isolated from intensive care units in Taiwan: results from the Surveillance of Multicentre Antimicrobial Resistance in Taiwan (SMART) in 2009. Int J Antimicrob Agents. 2013, 41: 457-462. 10.1016\/j.ijantimicag.2013.02.001.","journal-title":"Int J Antimicrob Agents"},{"key":"3787_CR22","first-page":"185","volume":"37","author":"SM Lau","year":"2004","unstructured":"Lau SM, Peng MY, Chang FY: Resistance rates to commonly used antimicrobials among pathogens of both bacteremic and non-bacteremic community-acquired urinary tract infection. J Microbiol Immunol Infect. 2004, 37: 185-191.","journal-title":"J Microbiol Immunol Infect"},{"key":"3787_CR23","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1186\/1471-2334-12-200","volume":"12","author":"SC Kuo","year":"2012","unstructured":"Kuo SC, Chang SC, Wang HY, Lai JF, Chen PC, Shiau YR, Huang IW, Lauderdale TL: Emergence of extensively drug-resistant Acinetobacter baumannii complex over 10 years: nationwide data from the Taiwan Surveillance of Antimicrobial Resistance (TSAR) program. BMC Infect Dis. 2012, 12: 200-10.1186\/1471-2334-12-200.","journal-title":"BMC Infect Dis"},{"key":"3787_CR24","volume-title":"Methods for Dilution Antimicrobial Susceptibility tests for Bacteria That Grow Aerobically; Approved Standard-Ninth Edition. CLSI documents M07-A09. Clinical and Laboratory Standards Institute","author":"Clinical and Laboratory Standards Institute","year":"2012","unstructured":"Clinical and Laboratory Standards Institute: Methods for Dilution Antimicrobial Susceptibility tests for Bacteria That Grow Aerobically; Approved Standard-Ninth Edition. CLSI documents M07-A09. Clinical and Laboratory Standards Institute. 2012, Wayne, PA, USA: CLSI"},{"key":"3787_CR25","volume-title":"Performance Standards for Antimicrobial Susceptibility Testing. Nineteenth Informational Supplement. M100-S19. Clinical and Laboratory Standards Institute (CLSI)","author":"Clinical and Laboratory Standards Institute","year":"2009","unstructured":"Clinical and Laboratory Standards Institute: Performance Standards for Antimicrobial Susceptibility Testing. Nineteenth Informational Supplement. M100-S19. Clinical and Laboratory Standards Institute (CLSI). 2009, Wayne, PA: CLSI, Document M100-S19"},{"key":"3787_CR26","doi-asserted-by":"publisher","first-page":"1400","DOI":"10.1111\/j.1600-0463.2007.00722.x","volume":"115","author":"HJ Monstein","year":"2007","unstructured":"Monstein HJ, Ostholm-Balkhed A, Nilsson MV, Nilsson M, Dornbusch K, Nilsson LE: Multiplex PCR amplification assay for the detection of bla\nSHV, bla\nTEM and bla\nCTX-M genes in Enterobacteriaceae. APMIS. 2007, 115: 1400-1408. 10.1111\/j.1600-0463.2007.00722.x.","journal-title":"APMIS"},{"key":"3787_CR27","doi-asserted-by":"publisher","first-page":"2153","DOI":"10.1128\/JCM.40.6.2153-2162.2002","volume":"40","author":"FJ Perez-Perez","year":"2002","unstructured":"Perez-Perez FJ, Hanson ND: Detection of plasmid-mediated AmpC \u03b2-lactamase genes in clinical isolates by using multiplex PCR. J Clin Microbiol. 2002, 40: 2153-2162. 10.1128\/JCM.40.6.2153-2162.2002.","journal-title":"J Clin Microbiol"},{"key":"3787_CR28","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1128\/CMR.00021-10","volume":"24","author":"TF O\u2019Brien","year":"2011","unstructured":"O\u2019Brien TF, Stelling J: Integrated multilevel surveillance of the world\u2019s infecting microbes and their resistance to antimicrobial agents. Clin Microbiol Rev. 2011, 24: 281-295. 10.1128\/CMR.00021-10.","journal-title":"Clin Microbiol Rev"},{"key":"3787_CR29","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1128\/AAC.01896-13","volume":"58","author":"M Castanheira","year":"2014","unstructured":"Castanheira M, Farrell SE, Krause KM, Jones RN, Sader HS: Contemporary diversity of \u03b2-lactamases among Enterobacteriaceae in the nine U.S. Census regions and ceftazidime-avibactam activity tested against isolates producing the most prevalent \u03b2-lactamase groups. Antimicrob Agents Chemother. 2014, 58: 833-838. 10.1128\/AAC.01896-13.","journal-title":"Antimicrob Agents Chemother"},{"key":"3787_CR30","doi-asserted-by":"publisher","first-page":"e37788","DOI":"10.1371\/journal.pone.0037788","volume":"7","author":"CH Su","year":"2012","unstructured":"Su CH, Wang JT, Hsiung CA, Chien LJ, Chi CL, Yu HT, Chang FY, Chang SC: Increase of carbapenem-resistant Acinetobacter baumannii infection in acute care hospitals in Taiwan: association with hospital antimicrobial usage. PLoS One. 2012, 7: e37788-10.1371\/journal.pone.0037788.","journal-title":"PLoS One"},{"key":"3787_CR31","volume-title":"MIC distributions","author":"European Committee on Antimicrobial Susceptibility Testing","year":"2012","unstructured":"European Committee on Antimicrobial Susceptibility Testing: MIC distributions. 2012, http:\/\/www.eucast.org\/mic_distributions\/ [Accessed 01.04.14]"},{"key":"3787_CR32","unstructured":"Centers for Diseases Control and Prevention: The CDC guidance for control of CRE-2012 CRE toolkit. Available from http:\/\/www.cdc.gov\/hai\/pdfs\/cre\/CRE-guidance-508.pdf,"},{"key":"3787_CR33","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1093\/cid\/cit017","volume":"56","author":"MN Dudley","year":"2013","unstructured":"Dudley MN, Ambrose PG, Bhavnani SM, Craig WA, Ferraro MJ, Jones RN: Background and rationale for revised clinical and laboratory standards institute interpretive criteria (breakpoints) for Enterobacteriaceae and Pseudomonas aeruginosa: I. Cephalosporins and aztreonam. Clin Infect Dis. 2013, 56: 1301-1309. 10.1093\/cid\/cit017.","journal-title":"Clin Infect Dis"},{"key":"3787_CR34","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/j.ijantimicag.2010.05.012","volume":"36","author":"SP Hawser","year":"2010","unstructured":"Hawser SP, Badal RE, Bouchillon SK, Hoban DJ, Hsueh PR: Comparison of CLSI 2009, CLSI 2010 and EUCAST cephalosporin clinical breakpoints in recent clinical isolates of Escherichia coli, Klebsiella pneumoniae and Klebsiella oxytoca from the SMART global surveillance study. Int J Antimicrob Agents. 2010, 36: 293-294. 10.1016\/j.ijantimicag.2010.05.012.","journal-title":"Int J Antimicrob Agents"},{"key":"3787_CR35","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1016\/j.diagmicrobio.2011.03.008","volume":"70","author":"TY Tan","year":"2011","unstructured":"Tan TY, Ng LS, He J, Chen DM: Improved detection of AmpC \u03b2-lactamases in Escherichia coli, Klebsiella pneumoniae, and Proteus mirabilis using new susceptibility breakpoints for third-generation cephalosporins. Diagn Microbiol Infect Dis. 2011, 70: 423-424. 10.1016\/j.diagmicrobio.2011.03.008.","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"Suppl 1","key":"3787_CR36","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1111\/j.1469-0691.2007.01867.x","volume":"14","author":"GM Rossolini","year":"2008","unstructured":"Rossolini GM, D\u2019Andrea MM, Mugnaioli C: The spread of CTX-M-type extended-spectrum \u03b2-lactamases. Clin Microbiol Infect. 2008, 14 (Suppl 1): 33-41.","journal-title":"Clin Microbiol Infect"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2334-14-486.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2334-14-486\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2334-14-486","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2334-14-486.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,2]],"date-time":"2021-09-02T01:39:51Z","timestamp":1630546791000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/1471-2334-14-486"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,9,5]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["3787"],"URL":"https:\/\/doi.org\/10.1186\/1471-2334-14-486","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,9,5]]},"assertion":[{"value":"13 April 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 September 2014","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 September 2014","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"486"}}